Computational Biology Platform that's Yielded a Pipeline of Experimentally-Validated New Drugs
Discovered new fundamental biology
We own [by granted patents]
and repurposed clinical stage drugs
Our mission is new drugs for cancer,
the diseases of aging (e.g., Alzheimer's disease),
and AGING itself (which has cosmetic applications)
Dr. Michael Forrest
Cambridge University biochemistry graduate.
Ph.D. computer science.
Professor George Church
Harvard Medical School
Professor Bruno Conti
Scripps Research Institute
Professor Varinder Aggarwal
Bristol University chemistry department. Robert Robinson lecturer at Oxford University.